As a result of GRAS process FDA has no idea of what’s on market, say paper’s authors
Heard about this paper? See what Ashish Talati has to say about it –
Contact
5185 MacArthur Blvd NW
Suite 230
Washington, D.C. 20016
PH:202.496.4966
515 South Flower Street
18th Floor
Los Angeles, CA 90071
PH:213.933.2330
Copyright 2025 by Amin Wasserman Gurnani, LLP | Privacy Statement | Terms Of Use
The content in the Amin Wasserman Gurnani web site may constitute attorney advertising or advertising material within the meaning of applicable bar rules, and/or under the Rules of Professional Conduct governing lawyers. Nothing in this site is to be considered as either creating an attorney-client relationship between the reader and Amin Wasserman Gurnani or as the rendering of legal advice for any specific matter.
